A detailed history of Baker Tilly Wealth Management, LLC transactions in Amgen Inc stock. As of the latest transaction made, Baker Tilly Wealth Management, LLC holds 2,946 shares of AMGN stock, worth $911,433. This represents 0.15% of its overall portfolio holdings.

Number of Shares
2,946
Previous 2,902 1.52%
Holding current value
$911,433
Previous $835,000 0.24%
% of portfolio
0.15%
Previous 0.14%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 09, 2024

BUY
$268.87 - $324.56 $11,830 - $14,280
44 Added 1.52%
2,946 $837,000
Q4 2023

Jan 10, 2024

SELL
$255.7 - $288.46 $27,359 - $30,865
-107 Reduced 3.56%
2,902 $835,000
Q3 2023

Oct 10, 2023

SELL
$218.65 - $271.46 $324,039 - $402,303
-1,482 Reduced 33.0%
3,009 $808,000
Q2 2023

Jul 20, 2023

SELL
$214.27 - $253.37 $49,282 - $58,275
-230 Reduced 4.87%
4,491 $997,000
Q1 2023

Apr 12, 2023

SELL
$225.79 - $275.2 $311,815 - $380,051
-1,381 Reduced 22.63%
4,721 $1.14 Million
Q4 2022

Jan 26, 2023

BUY
$229.03 - $291.01 $5,038 - $6,402
22 Added 0.36%
6,102 $0
Q3 2022

Oct 20, 2022

SELL
$224.46 - $253.15 $6,958 - $7,847
-31 Reduced 0.51%
6,080 $1.37 Million
Q2 2022

Jul 28, 2022

SELL
$230.71 - $256.74 $34,837 - $38,767
-151 Reduced 2.41%
6,111 $1.49 Million
Q1 2022

Apr 27, 2022

BUY
$219.27 - $242.57 $75,867 - $83,929
346 Added 5.85%
6,262 $1.51 Million
Q4 2021

Feb 08, 2022

SELL
$198.88 - $227.6 $85,518 - $97,868
-430 Reduced 6.78%
5,916 $1.33 Million
Q3 2021

Nov 02, 2021

BUY
$212.27 - $248.7 $71,110 - $83,314
335 Added 5.57%
6,346 $1.35 Million
Q2 2021

Jul 30, 2021

BUY
$233.58 - $259.14 $7,708 - $8,551
33 Added 0.55%
6,011 $1.47 Million
Q1 2021

Apr 28, 2021

BUY
$221.91 - $258.6 $440,047 - $512,803
1,983 Added 49.64%
5,978 $1.49 Million
Q4 2020

Feb 03, 2021

BUY
$216.38 - $257.67 $864,438 - $1.03 Million
3,995 New
3,995 $919,000

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $165B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Baker Tilly Wealth Management, LLC Portfolio

Follow Baker Tilly Wealth Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baker Tilly Wealth Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Baker Tilly Wealth Management, LLC with notifications on news.